Relmada Therapeutics Inc (RLMD) — Strategic Asset Allocation Index
Relmada Therapeutics Inc (RLMD) has a Strategic Asset Allocation Index of 0.0% as of March 2021. Strategic assets (PP&E of $452.00 plus long-term investments of $-) total $452.00, measured against net assets of $91.15 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See debt-free asset ratio of Relmada Therapeutics Inc to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Relmada Therapeutics Inc Strategic Asset Allocation Index (2014–2020)
This chart shows how Relmada Therapeutics Inc's Strategic Asset Allocation Index has evolved across 6 annual periods from 2014 to 2020. As of March 2021, the index stands at 0.0%, representing strategic assets of $452.00 against net assets of $91.15 Million USD. For live market cap and overall valuation, see Relmada Therapeutics Inc market capitalisation.
Annual Strategic Asset Allocation Index for Relmada Therapeutics Inc (2014–2020)
The table below presents the year-by-year Strategic Asset Allocation Index for Relmada Therapeutics Inc from 2014 to 2020, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Relmada Therapeutics Inc book value and equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2020 | 0.0% | $1.26K | $1.26K | $- | $105.58 Million | ▼ 0.0 pp |
| 2019 | 0.0% | $5.01K | $5.01K | $- | $115.68 Million | ▼ -0.8 pp |
| 2017 | 0.8% | $12.08K | $12.08K | $- | $1.46 Million | ▼ -4.0 pp |
| 2016 | 4.8% | $340.05K | $2.31K | $337.73K | $7.04 Million | ▼ -1.2 pp |
| 2015 | 6.0% | $531.35K | $531.35K | $- | $8.81 Million | ▲ +5.8 pp |
| 2014 | 0.3% | $23.91K | $23.91K | $- | $8.81 Million | — |